Nicholas Company Inc. increased its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 17.8% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 70,681 shares of the medical research company’s stock after acquiring an additional 10,695 shares during […]